Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Major Somatic Sensory Pathways01:28

Major Somatic Sensory Pathways

Sensory impulses related to touch, pressure, vibration, and proprioception from various body parts, such as the limbs, trunk, neck, and posterior head, travel to the cerebral cortex through the posterior column-medial lemniscus pathway. The pathway’s name derives from the two white-matter tracts that convey the impulses: the spinal cord's posterior column and the brainstem's medial lemniscus. First-order sensory neurons extend their axons into the spinal cord, forming the posterior columns...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Somatic Spinal Reflexes01:22

Somatic Spinal Reflexes

Somatic spinal reflexes are rapid, involuntary muscular responses to external stimuli that involve the somatic musculature and the spinal cord.
One of the most well-known somatic spinal reflexes is the stretch reflex, which is activated by the sudden stretching of a muscle. This reflex involves the activation of specialized sensory receptors called muscle spindles, which are located in the muscle tissue and detect changes in the length and speed of muscle contractions. When a muscle is suddenly...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study.

Journal of Alzheimer's disease : JAD·2022
Same author

Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia.

Neurobiology of aging·2021
Same author

Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration.

Journal of neuropathology and experimental neurology·2021
Same author

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease.

Acta neuropathologica communications·2021
Same author

Amyloid-β<sub>1-43</sub> cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations.

Alzheimer's research & therapy·2020
Same author

Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.

Acta neuropathologica·2020

Related Experiment Video

Updated: May 30, 2026

Cerebellar Regional Dissection for Molecular Analysis
08:51

Cerebellar Regional Dissection for Molecular Analysis

Published on: December 5, 2020

Spinocerebellar ataxia type 7.

Jean-Jacques Martin1

  • 1Institute Born-Bunge, University of Antwerp, Belgium. kean-jacques.martin@ua.ac.be

Handbook of Clinical Neurology
|August 11, 2011
PubMed
Summary

Spinocerebellar ataxia type 7 (SCA7) is a genetic disorder characterized by progressive vision loss and ataxia, caused by expanded CAG repeats in the ataxin-7 gene. Neuropathology varies with repeat length, impacting spinocerebellar pathways and retina.

Area of Science:

  • Neurogenetics
  • Molecular Medicine
  • Ophthalmology

Background:

  • Spinocerebellar ataxia type 7 (SCA7) is a progressive neurodegenerative disorder.
  • It is a polyglutamine expansion disease linked to increased CAG repeats in the ataxin-7 gene.
  • SCA7 exhibits dominant transmission and anticipation, affecting individuals globally.

Purpose of the Study:

  • To detail the genetic basis and clinical spectrum of Spinocerebellar ataxia type 7.
  • To correlate CAG repeat length with phenotypic severity and neuropathological findings.
  • To highlight current research directions focusing on ataxin-7 function.

Main Methods:

  • Molecular genetic analysis to determine CAG repeat numbers.
  • Clinical assessment of visual and ataxic disturbances.

More Related Videos

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

Related Experiment Videos

Last Updated: May 30, 2026

Cerebellar Regional Dissection for Molecular Analysis
08:51

Cerebellar Regional Dissection for Molecular Analysis

Published on: December 5, 2020

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

  • Neuropathological examination of affected tissues, including spinocerebellar tracts and retina.
  • In vitro studies using transfected neural cells and in vivo studies using transgenic mouse models.
  • Main Results:

    • CAG repeat numbers range from 4-18 (normal), 18-35 (asymptomatic carrier), 36-43 (slow progression, minimal retinal issues), 50-55 (classic phenotype with visual/ataxic symptoms), and >100 (severe infantile phenotype).
    • Phenotypic severity, including visual impairment and ataxia, directly correlates with the number of expanded CAG repeats.
    • Neuropathology shows atrophy in specific neural pathways and cone-rod dystrophy, with ataxin-7 inclusions present.

    Conclusions:

    • SCA7 diagnosis relies on molecular genetics, with CAG repeat expansion being the key factor.
    • The number of CAG repeats dictates the severity and progression of SCA7, influencing both neurological and ophthalmological manifestations.
    • Ongoing research into ataxin-7 function in cellular and animal models is crucial for understanding and potentially treating SCA7.